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Abstract The DNA-binding activity of the Shigella £exneri
VirB transcription factor was studied in vitro. The protein
was found to bind non-speci¢cally to DNA, but showed prefer-
ential binding to VirB-dependent promoter sequences. DNA
binding was contingent on the presence of an intact helix-turn-
helix motif. While high molecular mass protein^DNA com-
plexes were formed in both speci¢c and non-speci¢c interactions
with DNA, mutant derivatives of VirB lacking a leucine zipper
domain or a carboxyl-terminal-located oligomerisation domain
formed discrete complexes, indicating that an ability to oligo-
merise on DNA was responsible for the formation of high mo-
lecular mass complexes by the wild-type protein.
& 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Shigella £exneri is a Gram-negative facultative enteroinva-
sive pathogen which infects the lower intestinal epithelia of
humans and primates to cause bacillary dysentery. Shigellosis
is a serious global health problem, causing around 600 000
deaths per annum, predominantly in the developing world
[1]. Invasion of host cells by S. £exneri requires expression
of virulence genes located on a 230 kb plasmid. The products
of these genes include the Ipa invasins, which mediate the
invasion of gut epithelia and macrophage apoptosis [2,3],
the Mxi and Spa proteins which form a type III secretion
system [4], and the IcsA, IcsB and VirA proteins which are
responsible for intercellular spreading of bacteria in the lower
gut [5^7]. The virulence genes are expressed only under con-
ditions approximating those found at the site of infection, i.e.
at 37‡C, a pH of 7.4 and moderate osmolarity [8^10]. A tran-
scriptional regulatory cascade, involving both chromosomally
encoded proteins including IHF (integration host factor) and
H-NS (histone-like nucleoid structuring protein) and plasmid-
borne regulatory proteins, VirF and VirB, integrates environ-
mental signals and restricts the expression of structural viru-
lence genes to the appropriate conditions [7,11^14].
The transcriptional cascade regulating the activation of vir-
ulence gene expression is initiated with the expression of the
VirF protein, an AraC-like transcriptional regulator [10,14].
VirF is responsible for the activation of the virB regulatory
and icsA structural genes [9,15]. The VirB protein then acti-
vates the other structural genes required for virulence [16^18].
The expression of virB is also regulated by H-NS, which acts
as an antagonist to VirF at the promoter, and together with
levels of negative DNA supercoiling, this appears to be re-
sponsible for the thermo-sensitivity of virB expression [19^
21].
The role of the VirB protein in the regulation of virulence
gene expression in S. £exneri was identi¢ed through transpo-
son mutagenesis of the large virulence plasmid, when it was
shown to be essential for the expression of almost all of the
structural virulence genes [18]. VirB is an unusual candidate
for a transcriptional activator, sharing homology with a fam-
ily of plasmid partition proteins, including the ParB and SopB
proteins, rather than previously described conventional tran-
scriptional regulators [18,22,23]. Small and basic, VirB has
been shown to form dimers, trimers and higher oligomers
both in vivo and in vitro [17]. Oligomerisation is independent
of DNA binding [17] and occurs through two domains, a
leucine zipper located between residues 193 and 228 and a
region at the C-terminus predicted to form a triple coil struc-
ture (Fig. 1A) [17]. Also, VirB binds speci¢cally to target
structural gene promoters in vivo [17]. The ability of VirB
to interact with DNA in vivo is dependent on the presence
of the N-terminus and the integrity of a helix-turn-helix
(HTH) DNA-binding motif, located between residues 148
and 171, and essential for structural gene activation (Fig.
2A) [17]. Oligomerisation of the protein contributes to DNA
binding since oligomerisation mutants bind to DNA with a
lower preference in vivo [17]. The interaction with virulence
gene promoters implies that activation by VirB is direct, how-
ever the mechanism is unclear (Fig. 1B). It has recently been
shown that H-NS also binds directly to these promoters where
it acts antagonistically to VirB [24].
The HTH DNA-binding motif in VirB is 80% identical to
the HTH in the homologous ParB protein of plasmid P1,
which mediates binding of ParB to the parS site leading to
plasmid partitioning [17,25,26]. Interestingly there appears to
be no consensus sequence analogous to parS for VirB DNA
binding, and no homology exists between the four promoters
to which VirB binds.
Although chromatin immunoprecipitation experiments indi-
cate that VirB interacts speci¢cally with target promoters in
vivo [17], binding has never been demonstrated directly. This
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study investigates the binding of the VirB protein to target
promoter DNA in vitro and assesses the importance of the
HTH motif and the role of oligomerisation in VirB binding to
DNA. Evidence is presented that the VirB protein polymerises
on DNA in vitro echoing a phenomenon observed in vivo
with the ParB and SopB proteins [27,28]. This raises interest-
ing questions about the nature of DNA binding in vivo and
the mechanisms by which VirB may activate structural gene
expression.
2. Materials and methods
2.1. Bacterial strains plasmids and growth conditions
Plasmids were derivatives of the pET19b Novagen vector contain-
ing VirB, or VirB mutants K152E, K164E, L224R, vLZ, or v244^309
[17]. Proteins were expressed in Escherichia coli K-12 strain BL21DE3
containing the LacI-expressing plasmid pDIA17. Cells were grown in
Luria^Bertani broth containing chloramphenicol (20 Wg/ml) and car-
benicillin (50 Wg/ml) at 30‡C.
2.2. Puri¢cation of VirB
Expression of N-terminally His-tagged VirB was induced with 0.1
mM IPTG in exponentially growing 500 ml cultures. After 3 h the
cells were harvested and lysed in a French pressure cell. Lysates (V15
ml) were applied to a His-Bind0 Quick column (Novagen) pre-equil-
ibrated with binding bu¡er [17]. The column was then washed with
binding bu¡er (50 ml) and wash bu¡er (25 ml) [17] and the protein
eluted in 1 ml fractions of 2U15 ml of elution bu¡er (10% glycerol, 50
mM Tris^HCl pH 7.9, 0.5 M NaCl, 0.1 mM phenylmethylsulfonyl
£uoride (PMSF)) containing 100 mM imidazole and 500 mM imida-
zole. Fractions were analysed by SDS^PAGE and those containing
VirB were pooled and dialysed three times against 1 l 50 mM Tris^
HCl pH 7.5, 1 mM EDTA pH 8, 300 mM NaCl, 5% glycerol, 0.1 mM
PMSF, 1 mM dithiothreitol (DTT). VirB was estimated to be approx-
imately 95% pure. Preparation and use of anti-VirB rabbit polyclonal
antibodies was described previously [17]. The His-tagged wild-type
protein was found to be fully functional in vivo (data not shown).
2.3. Small scale protein puri¢cation
VirB and VirB mutants for use in electrophoretic mobility shift
assays were puri¢ed from crude extracts by metal a⁄nity chromatog-
raphy using the His-Bind Magnetic Beads (Novagen). Induction of
protein expression and cell lysis were performed as described above.
1.5 ml of the soluble extract was applied to 500 Wl of pre-equilibrated
beads in a 2 ml microfuge tube and incubated for 5 min. The magnetic
beads were pelleted using a magnetic rack (Novagen) and the super-
natant removed. The remaining soluble extract was applied to the
beads as before and the beads were then washed three times with
2 ml wash bu¡er (as before) to remove contaminating proteins. Bound
protein was eluted with 500 mM imidazole and analysed by SDS^
PAGE. Proteins puri¢ed in this manner were deemed to be 85^90%
pure by SDS^PAGE followed by Coomassie staining, and were dia-
lysed in storage bu¡er (as above) and stored at 320‡C.
2.4. Electrophoretic mobility shift analysis of protein^DNA interactions
A 340 bp DNA fragment encompassing the icsB-ipgD promoter
region was ampli¢ed by the polymerase chain reaction using oligonu-
cleotide primers IcsB5P 5P-TATAGGTCCTGTATTGCTTGCCTGA-
AT-3P and IcsB3P 5P-AAATGAGGATCCATGCAATCCCAAATTA-
GT-3P. A 350 bp DNA fragment internal to the icsP gene was
ampli¢ed with primers IcsP5P 5P-ACTCTCGACTTTAAAAGGATG-
GGA-3P and 5P-CTACTCACCTTCTTGTTCTCTCGC-3P. Radiola-
belled probe DNA was incubated with increasing concentrations of
His-tag-puri¢ed wild-type VirB or mutant VirB for 20 min at room
temperature in a 20 Wl reaction cocktail containing 10% glycerol,
1 mM EDTA, 1 mM DTT, 0.1 mM PMSF, 20 mM Tris^HCl pH 8,
50 mM KNa and 2 mM spermidine. Similar results were obtained
when these mixtures were incubated at 30‡C or 37‡C. Each reaction
mixture contained 1.45 WM DNA (5 ng) and VirB protein concentra-
tions in the range 0^500 WM. Protein^DNA complexes were resolved
by electrophoresis through an 8% polyacrylamide gel, for 4 h at 4‡C.
The gel was dried under vacuum onto Whatmann 3 MM paper and
examined by autoradiography.
3. Results and discussion
3.1. Ability of puri¢ed VirB protein to bind to target promoter
DNA
The icsB-ipgD intergenic region was selected as the target
DNA in electrophoretic mobility shift assays, as this region
contains the promoters for two divergently transcribed VirB-
dependent operons (Fig. 1). A DNA fragment internal to the
open reading frame of the icsP gene was used as a negative
control. Binding reactions with increasing concentrations of
(His)10-VirB protein were carried out in an optimised bu¡er at
room temperature.
Puri¢ed VirB showed a higher preference for binding to
icsB-ipgD DNA than to icsP DNA (Fig. 2). At a protein:
DNA molar ratio of 4:1, the icsB-ipgD probe begins to be
shifted to the wells in the presence of 6.25 WM VirB (Fig. 2A).
In contrast, the icsP probe requires a protein:DNA molar
ratio of 80:1 (125 WM VirB in the reaction mixture) to achieve
a comparable shift (Fig. 2B). VirB was observed to display a
similar preference for binding to the spa and virA structural
gene promoters in vitro as it does for icsB-ipgD (data not
shown). These results indicate that VirB probably binds di-
rectly to the target promoters in vivo to e¡ect the activation
of structural gene expression, which is consistent with pre-
vious ¢ndings from in vivo analyses [17].
Interestingly, no discrete protein^DNA complexes, which
normally indicate the attachment of an active protein to its
binding site on DNA via an HTH motif [29], were observed in
the binding of VirB to either probe. One possible explanation
for this pattern is that VirB binds to DNA as a large complex.
Another possibility is that on binding, VirB polymerises rap-
Fig. 1. Model of structural domains and activity of the VirB pro-
tein. The organisation of structural domains within the VirB protein
is shown in schematic form in A. Structural features of the protein,
their positions and their functions are highlighted on the diagram.
Mutagenesis data have shown that a domain with a role in gene ac-
tivation and a structural role in DNA binding is located between
residues 1 and 65 and may extend to residue 148 [17]. A model for
the activation of structural gene expression is shown in B. VirB
binds directly at these promoters to activate gene expression, prob-
ably acting as an antagonist to the H-NS repressor [24].
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idly along the DNA, forming a large complex that traps the
probes in the gel wells. With the exception of di¡ering binding
preferences, the pattern of binding appears similar for both
the target promoter DNA and the negative control DNA.
Indeed, in further bandshift experiments VirB was capable
of shifting many unrelated DNA probes in a similar manner
(data not shown), but it always showed a strong preference
for binding to target DNAs that contained VirB-dependent
promoters. We are con¢dent that VirB is not aggregating in
these in vitro assays, and that it does not aggregate in vivo.
Previously we have performed cross-linking experiments in
vitro (without DNA) and in vivo (with DNA) ([17] and un-
published data). Complexes of VirB up to 10-mer could be
detected in the presence of cross-linker but the protein was
not found to form complexes that became trapped in the wells
of the gel. In the absence of cross-linker dimers and trimers
were dominant, something that would not be expected if the
protein was merely prone to aggregation.
3.2. Puri¢cation of VirB mutants
To test the e¡ect of mutations in the HTH putative DNA-
binding motif of VirB on the ability of the protein to bind
DNA, the K152E and K164E mutants were puri¢ed for use in
electrophoretic mobility shift assays. Both of these proteins
contain mutations at key residues in the motif, proposed to
disrupt protein^DNA interactions [17]. These changes were
previously shown to abolish the ability of VirB to activate
structural gene transcription, without a¡ecting the oligomeric
state of the protein [17]. To test the requirement for oligomer-
isation in the DNA-binding activity of VirB, several represen-
tative mutants that had been shown to be defective in oligo-
merisation, L224R, vLZ, and v244^309 [17], were also
puri¢ed. An attempt was made to purify a truncate lacking
the N-terminus of the protein, to examine the role of that
region in DNA binding, but this protein proved unstable
when overexpressed. The proteins were puri¢ed as described
in Section 2 and were judged to be s 90% pure by SDS^
PAGE and densitometric analysis (Fig. 3).
3.3. Ability of VirB HTH mutants to bind DNA in vitro
The observation that mutagenesis of key charged residues
in the HTH DNA-binding motif of VirB abolished the ability
of the protein to activate structural gene expression and re-
duced in vivo binding of VirB to promoters of the virulence
structural genes [17], indicated that this motif was functional
and contributed to DNA binding by VirB in S. £exneri. To
Fig. 2. Binding of puri¢ed recombinant VirB to DNA in vitro. Gel
mobility shift analysis of VirB interactions with the target promoter
icsB-ipgD DNA and control icsP DNA. Increasing amounts of puri-
¢ed recombinant (His)10-VirB (indicated below each gel) were incu-
bated with 1.45 WM 32P-labelled icsB-ipgD (A) and icsP (B) DNA
fragments for 20 min at room temperature. Bound and free probes
were separated by polyacrylamide gel electrophoresis and visualised
by autoradiography. The migration of free and bound probes is in-
dicated with arrows.
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Fig. 3. Puri¢cation of recombinant VirB mutants. SDS^PAGE anal-
ysis of overexpression and puri¢cation of the VirB mutant K164E is
shown in A. Strain BL21 (DE3)/pDIA17 harbouring the overexpres-
sion plasmid pET19K164E was grown to the mid-exponential phase,
and virB expression induced by the addition of 0.1 mM IPTG. Pro-
tein samples of induced (+) and uninduced (3) culture, the insolu-
ble and soluble fraction prior to passage over a Ni2þ-charged col-
umn, and the elution fractions are indicated on the gel. The band
corresponding to K164E is indicated with a horizontal arrow.
B shows SDS^PAGE analysis of 1 Wg of each of the VirB mutants
puri¢ed to show concentration, purity and integrity of the proteins.
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con¢rm directly the disruption of protein^DNA interactions
by these mutations, puri¢ed K152E and K164E were used in
electrophoretic mobility shift assays. Fig. 4 shows the results
of binding reactions of the HTH mutants with an icsB-ipgD
promoter probe and an icsP control probe. Clearly both of
the HTH mutants were unable to bind to either promoter
DNA or to the negative control icsP DNA, in contrast to
the wild-type VirB protein binding to the icsB-ipgD probe
(Fig. 4). In some cases, small quantities of probe were trapped
in the wells spontaneously, even in the absence of any protein
(for example, Fig. 4B; icsP probe). The reasons for this are
not known. These results are consistent with the HTH motif
in VirB being functional and contributing to the DNA-bind-
ing ability of the protein. By implication, HTH mutations
would block gene activation by VirB in S. £exneri because
they render the protein unable to bind to DNA. In previous
work we have shown that these HTH mutants remain fully
functional for oligomerisation in vitro [17] so the e¡ects re-
ported here are unlikely to involve de¢ciencies in protein^
protein interaction. VirB di¡ers from other DNA-binding
proteins having an HTH motif in apparently not binding to
Fig. 4. Ability of VirB HTH mutants to bind DNA in vitro. Gel
mobility shift analysis of interactions of the K152E and K164E
HTH mutants of VirB with the target promoter icsB-ipgD DNA
and control icsP DNA. Increasing amounts (indicated below each
gel) of puri¢ed recombinant (His)10-K152E (A) and (His)10-K164E
(B) were incubated with 1.45 WM 32P-labelled icsB-ipgD or icsP
DNA fragments for 20 min at room temperature. Bound and free
probes were separated by polyacrylamide gel electrophoresis and vi-
sualised by autoradiography. The migration of free probes is indi-
cated with arrows. In each case, the mobility shift achieved with
62.5 WM wild-type VirB protein binding to the icsB-ipgD probe in a
40:1 protein:DNA molar ratio is shown for comparison in the lane
on the extreme right.
Fig. 5. Ability of oligomerisation de¢cient VirB mutants to bind
DNA in vitro. Gel mobility shift analysis of interactions of the
L224R, vLZ and v244^309 oligomerisation de¢cient mutants of
VirB with the target promoter icsB-ipgD DNA and control icsP
DNA. Increasing amounts (indicated below each gel) of puri¢ed re-
combinant (His)10-L224R (A), (His)10-vLZ (B) and (His)10-v244^
309 (C) were incubated with 1.45 WM 32P-labelled icsB-ipgD and
icsP DNA fragments for 20 min at room temperature. Bound and
free probes were separated by polyacrylamide gel electrophoresis
and visualised by autoradiography. The migration of free and
bound probes is indicated with arrows. In each case, the mobility
shift achieved with 62.5 WM wild-type VirB protein binding to the
icsB-ipgD probe in a 40:1 protein:DNA molar ratio is shown for
comparison in the lane on the extreme right.
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a consensus binding site [29,30] and may, like its antagonist
H-NS, bind to a consensus structure in DNA [31]. If so, other
aspects of VirB may contribute to the speci¢city of its binding
activity.
3.4. Ability of oligomerisation de¢cient mutants of VirB to bind
DNA in vitro
To test the role of oligomerisation in the ability of VirB to
bind DNA, three mutants, L224R, vLZ, and v244^309, were
puri¢ed for use in bandshift assays (Fig. 3B). These mutants
had previously been shown to have a reduced capacity to
oligomerise in vivo [17]. All of the oligomerisation de¢cient
mutants showed a reduced preference for promoter icsB-ipgD
DNA and the icsP internal DNA compared with wild-type
VirB in vitro (Fig. 5). Unlike the native protein, none of the
mutants was capable of fully shifting the DNA probes at any
protein:DNA molar ratio tested, indicating that VirB prob-
ably interacts with DNA most e⁄ciently in its oligomeric
form. This is in agreement with in vivo experiments showing
a reduced DNA-binding capacity for VirB mutants impaired
in oligomerisation [17].
Interestingly the VirB mutants with an inability to oligo-
merise showed a di¡erent pattern of binding to the icsB-ipgD
promoter DNA to the wild-type protein (Fig. 5). Wild-type
VirB shifted the promoter DNA probe directly into the wells,
whereas each of the oligomerisation de¢cient mutants pro-
duced a single intermediate complex of the protein with pro-
moter DNA before a shift into the wells (Fig. 5). Thus it
appears that the L224R, vLZ, and v244^309 mutants form
an initial complex with DNA, followed by polymerisation of
the protein on the DNA forming high molecular weight com-
plexes that remain in the wells of the gel. The reduced ability
of these proteins to interact with each other appears to slow
this reaction su⁄ciently to separate initial complex formation
from oligomerisation. The L224R and the vLZ mutants
bound to and shifted promoter DNA at a protein:DNA mo-
lar ratio of 40:1, a ratio at which the wild-type shifted the
probe completely to the wells. The v244^309 mutant formed
the intermediate complex only at a protein:DNA molar ratio
of 218:1, possibly indicative of the severity of the carboxyl-
terminal deletion that removed a major oligomerisation do-
main.
Thus it appears that oligomerisation of the VirB protein
plays a key role in the binding of the protein to DNA in vitro.
Proteins defective for oligomerisation showed a reduced pref-
erence for promoter DNA and a di¡erent binding pattern
compared with native VirB. The results presented here dem-
onstrate direct binding of the VirB protein to target pro-
moters in vitro for the ¢rst time. In addition they are consis-
tent with an essential role for the HTH motif in this DNA-
binding activity. Finally it appears that oligomerisation of
VirB is also required for e¡ective DNA binding and there is
an indication that VirB possesses the ability to polymerise
along DNA in vitro, possibly echoing a similar phenomenon
described in vivo for the homologous ParB and SopB plasmid
partitioning proteins [26^28]. Perhaps VirB has evolved from
a plasmid partition function that was diverted to a role as a
regulator of virulence genes. The S. £exneri plasmids possess
dedicated partition functions related in amino acid sequence
to VirB [32,33] and this redundancy might have permitted
such an event to occur.
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